![David-Alexandre Gros](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 13 M $ al 31/05/2026
David-Alexandre C.
Gros was the founder of Climb Bio, Inc., founded in 2018, where the title held was Director from 2018 to 2020.
Dr. Gros was the founder of Imbria Pharmaceuticals, Inc., founded in 2018, where the title held was Chairman & Chief Executive Officer from 2018 to 2020.
The current job is Chief Executive Officer & Director at Eledon Pharmaceuticals, Inc. starting in 2020.
Former jobs include President, Chief Operating & Financial Officer at Neurocrine Biosciences, Inc. in 2017; Chief Strategy Officer & Executive Vice President at Sanofi from 2013 to 2015; Associate Principal at McKinsey & Co., Inc. from 2002 to 2006; Chief Financial Officer at Alnylam Pharmaceuticals, Inc. from 2016 to 2017; Member-Supervisory Board at Saint Jean Groupe SA from 2014 to 2015; Principal at Centerview Partners LLC from 2009 to 2011; and Chief Strategy Officer at Sanofi from 2011 to 2015.
Education includes an undergraduate degree from Dartmouth College in 1995, a doctorate from The Johns Hopkins University School of Medicine in 1999, and an MBA from Harvard Business School in 2002.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
SAINT JEAN GROUPE SA 15,62 % | 07/05/2026 | 500.000 ( 15,62 % ) | 13 M $ | 31/05/2026 |
| 31/03/2026 | 9.000 ( 0,01 % ) | 34 290 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ELEDON PHARMACEUTICALS, INC. | Director Ejecutivo | 09/09/2020 |
| Empresas | Cargo | Fin |
|---|---|---|
| CLIMB BIO, INC. | Fundador | 01/10/2020 |
Imbria Pharmaceuticals, Inc.
 Imbria Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage company for the treatment of cardiovascular disease | Director Ejecutivo | 01/09/2020 |
| NEUROCRINE BIOSCIENCES, INC. | Presidente | 31/12/2017 |
| ALNYLAM PHARMACEUTICALS, INC. | Director Financiero/CFO | 06/01/2017 |
| SAINT JEAN GROUPE | Director/Miembro de la Junta | 01/07/2015 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 12 |
|---|---|
Neurocrine Biosciences, Inc.
 Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Saint Jean Groupe SA
 Saint Jean Groupe SA Food: Major DiversifiedConsumer Non-Durables Operates as an investment holding company with the interest in agro foods sector | Consumer Non-Durables |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Centerview Partners LLC
 Centerview Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eledon Pharmaceuticals, Inc.
 Eledon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Imbria Pharmaceuticals, Inc.
Imbria Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage company for the treatment of cardiovascular disease | Commercial Services |
Eliem Therapeutics, Inc.
 Eliem Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
